Polymeric nanoparticles as delivery system for influenza virus glycoproteins.

The objective of this work was to develop a new delivery system which could enhance the mucosal immune response to influenza virus antigens. Poly(D,L-lactide-co-glycolide) nanoparticles of about 200 nm containing hemagglutinin were chosen as the delivery system. Due to the amphiphilic nature of hemagglutinin (hydrophilic HA1 and hydrophobic HA2), nanoparticles were prepared by both classical oil in water solvent evaporation technique as well as by a [(water-in-oil) in water] solvent evaporation technique. Hemagglutinin was well encapsulated in nanoparticles prepared by both techniques. Molecular weight and antigenicity of entrapped hemagglutinin were not affected by the entrapment procedure.

[1]  M. Alonso,et al.  Approaches to improve the association of amikacin sulphate to poly(alkylcyanoacrylate) nanoparticles , 1991 .

[2]  J. Kreuter,et al.  In vitro studies of poly(methyl methacrylate) adjuvants. , 1976, Journal of pharmaceutical sciences.

[3]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[4]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[5]  S. Greenland,et al.  Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. , 1986, Vaccine.

[6]  J. Biewenga,et al.  The role of nasopharyngeal lymphoid tissue. , 1992, Immunology today.

[7]  R. Hawkes,et al.  A dot-immunobinding assay for monoclonal and other antibodies. , 1982, Analytical biochemistry.

[8]  G W Halbert,et al.  The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats , 1989, The Journal of pharmacy and pharmacology.

[9]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[10]  C. Thies,et al.  The formation and characterization of hydrocortisone‐loaded poly((±)‐lactide) microspheres , 1986, The Journal of pharmacy and pharmacology.

[11]  C W Potter,et al.  Determinants of immunity to influenza infection in man. , 1979, British medical bulletin.

[12]  Robert Gurny,et al.  Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .

[13]  S. Davis,et al.  The preparation and characterisation of poly(lactide-co-glycolide) microparticles. I: Oil-in-water emulsion solvent evaporation , 1991 .

[14]  T Yashiki,et al.  A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. , 1988, Chemical & pharmaceutical bulletin.

[15]  R. Walker,et al.  New strategies for using mucosal vaccination to achieve more effective immunization. , 1994, Vaccine.

[16]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[17]  J. Eldridge,et al.  Biodegradable microspheres: vaccine delivery system for oral immunization. , 1989, Current topics in microbiology and immunology.

[18]  V. Préat,et al.  Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). , 1996, Biomaterials.

[19]  C. Merril,et al.  A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. , 1979, Analytical biochemistry.

[20]  Simon Benita,et al.  Microencapsulation : methods and industrial applications , 1996 .

[21]  F. Ennis,et al.  New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion. , 1980, Journal of biological standardization.

[22]  G. K. Hirst.  THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION , 1942, The Journal of experimental medicine.

[23]  P. Rohdewald,et al.  Polylactic acid nanoparticles, a colloidal drug delivery system for lipophilic drugs , 1985 .

[24]  Thomas R. Tice,et al.  Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .

[25]  J. Mcghee,et al.  The mucosal immune system: from fundamental concepts to vaccine development. , 1992, Vaccine.

[26]  R. Bodmeier,et al.  Indomethacin polymeric nanosuspensions prepared by microfujidization , 1990 .

[27]  R. Gupta,et al.  Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. , 1994, Vaccine.

[28]  A. Coombes,et al.  The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery , 1993 .

[29]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. G. Laver,et al.  Identification in a recombinant influenza virus of structural proteins derived from both parents. , 1966, Virology.

[31]  M. Ueda,et al.  A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses. , 1970, The Journal of infectious diseases.

[32]  R. Compans,et al.  Oral immunization with influenza virus in biodegradable microspheres. , 1993, The Journal of infectious diseases.